Surgery Partners, Inc. - Common Stock, par value $0.01 per share (SGRY)

Historical Holders from Q4 2015 to Q3 2025

Symbol
SGRY on Nasdaq
CUSIP
86881A100
Type / Class
Equity / Common Stock, par value $0.01 per share
Shares outstanding
128M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
151M
Holdings value
$3.28B
% of all portfolios
0.007%
Grand Portfolio weight change
+0%
Number of holders
191
Number of buys
96
Number of sells
-94
Average Value change %
+0%
Average buys %
+0.002%
Average sells %
-0.002%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Surgery Partners, Inc. - Common Stock, par value $0.01 per share (SGRY)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BCPE Seminole Holdings LP 23.45% -0.63% $699M 30.1M 0% BCPE Seminole Holdings II Intermediate, LP Jun 16, 2025
JANUS HENDERSON GROUP PLC 10.2% +1% $282M $1.77M 13M +0.63% JANUS HENDERSON GROUP PLC Sep 30, 2025
Pentwater Capital Management LP 9.1% +60% $253M $101M 11.7M +66.9% Pentwater Capital Management LP Sep 30, 2025
FMR LLC 7.9% -36.9% $206M -$125M 10M -37.8% FMR LLC Mar 31, 2025
KING STREET CAPITAL MANAGEMENT, L.P. 7.2% $202M 9.34M King Street Capital Management, L.P. Oct 30, 2025
BlackRock, Inc. 4.4% $116M 5.68M BlackRock, Inc. Mar 31, 2025
WELLINGTON MANAGEMENT GROUP LLP 0% -93.3% $4.82K -$158M 217 -100% Wellington Management Group LLP Jun 30, 2025

Institutional Holders of Surgery Partners, Inc. - Common Stock, par value $0.01 per share (SGRY)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 151M $3.28B +$151M $21.64 191
2025 Q2 144M $3.21B +$96.6M $22.23 198
2025 Q1 140M $3.32B -$14.3M $23.75 203
2024 Q4 142M $3B +$37.1M $21.17 179
2024 Q3 137M $4.42B -$113M $32.24 185
2024 Q2 142M $3.38B +$125M $23.79 176
2024 Q1 136M $4.06B +$13M $29.83 178
2023 Q4 30.1K $964K -$368K $31.99 1
2023 Q3 134M $3.92B +$11.9M $29.25 162
2023 Q2 132M $5.94B +$130M $44.99 165
2023 Q1 130M $4.48B +$66.9M $34.47 151
2022 Q4 129M $3.59B +$963M $27.86 156
2022 Q3 93.6M $2.19B +$8.47M $23.40 124
2022 Q2 92.4M $2.67B +$37M $28.92 131
2022 Q1 90.3M $4.97B +$127M $55.05 138
2021 Q4 87.9M $4.69B +$406M $53.41 130
2021 Q3 80.7M $3.42B +$9.14M $42.34 132
2021 Q2 80.4M $5.35B +$1.56B $66.62 132
2021 Q1 57.3M $2.53B +$478M $44.26 116
2020 Q4 47.6M $1.38B -$19.2M $29.01 110
2020 Q3 47.4M $1.04B +$2.99M $21.90 97
2020 Q2 48.2M $558M +$26.5M $11.57 95
2020 Q1 47M $306M -$2.78M $6.53 79
2019 Q4 45.6M $716M -$26M $15.65 95
2019 Q3 47.5M $351M -$7.92K $7.39 82
2019 Q2 47.6M $387M -$362K $8.14 86
2019 Q1 47.8M $539M +$3.16M $11.28 79
2018 Q4 47.5M $465M -$7.76M $9.79 78
2018 Q3 47.2M $779M -$4.28M $16.50 76
2018 Q2 47.7M $711M -$2.08M $14.90 80
2018 Q1 48M $824M -$18.4M $17.15 80
2017 Q4 49.3M $596M +$37.2M $12.10 81
2017 Q3 46M $476M +$238M $10.35 86
2017 Q2 18.6M $424M -$7.86M $22.75 86
2017 Q1 19M $370M +$43.5M $19.50 84
2016 Q4 18.1M $287M -$13.6M $15.85 87
2016 Q3 18.7M $378M -$19.7M $20.24 84
2016 Q2 18.5M $332M +$30.6M $17.90 82
2016 Q1 17.3M $229M +$10.5M $13.26 60
2015 Q4 16.3M $333M +$333M $20.49 59